Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

1.4K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Triple-Microenvironment Decoding Enables Logic-Unlocked Precision Photoimmunotherapy.

Angewandte Chemie (International ed. in English)·2026
Same author

Development of Glycosylated and Dimeric FAP-Targeted Radiotracers for Preclinical Evaluation in FAP-Positive Glioblastoma Models.

Journal of medicinal chemistry·2026
Same author

Localized Depletion of Macrophages by Abdominal Cavity Retention Nanoparticles as a Potential Therapy for Peritoneal Metastasis.

ACS nano·2026
Same author

Pathology-Responsive Nanoprobes for NIR-II Imaging of Acute Kidney Injury.

Analytical chemistry·2026
Same author

Bridging hydrogen-bond-stabilized polymeric coacervate core micelles for high-efficiency drug encapsulation and delivery.

Nature communications·2026
Same author

A dual lock-and-key activated theranostic tool for highly specific near-infrared imaging and photodynamic/chemodynamic synergistic therapy of hepatocellular carcinoma.

Materials horizons·2026

Related Experiment Video

Updated: Dec 9, 2025

Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles
09:28

Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles

Published on: November 17, 2018

11.9K

Nanoparticle-enhanced chemo-immunotherapy to trigger robust antitumor immunity.

Jingjing Liang1, Huifang Wang2, Wenxiu Ding3

  • 1Department of Radiology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou 310016, China.

Science Advances
|September 14, 2020
PubMed
Summary

This study developed novel nanoparticles to combine chemotherapy and immunotherapy, effectively converting "cold" tumors into "hot" tumors for enhanced cancer treatment. This approach overcomes key challenges in current cancer immunotherapy strategies.

More Related Videos

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination
11:07

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Published on: April 29, 2015

13.6K
Inducing Targeted Mild Hyperthermia in Murine Tumor Models through Photothermal Conversion of Near-infrared Light by Intratumoral Gold Nanorods
09:23

Inducing Targeted Mild Hyperthermia in Murine Tumor Models through Photothermal Conversion of Near-infrared Light by Intratumoral Gold Nanorods

Published on: October 10, 2025

1.2K

Related Experiment Videos

Last Updated: Dec 9, 2025

Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles
09:28

Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles

Published on: November 17, 2018

11.9K
Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination
11:07

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Published on: April 29, 2015

13.6K
Inducing Targeted Mild Hyperthermia in Murine Tumor Models through Photothermal Conversion of Near-infrared Light by Intratumoral Gold Nanorods
09:23

Inducing Targeted Mild Hyperthermia in Murine Tumor Models through Photothermal Conversion of Near-infrared Light by Intratumoral Gold Nanorods

Published on: October 10, 2025

1.2K

Area of Science:

  • Oncology
  • Nanomedicine
  • Immunology

Background:

  • Immunotherapies show promise for cancer treatment but face challenges like immunosuppressive tumor microenvironments (TME).
  • Poor immunogenicity and off-target toxicity limit the widespread use of current immunotherapies.
  • Modulating the TME is crucial for improving immunotherapy efficacy.

Purpose of the Study:

  • To develop a novel nanosystem for combined chemotherapy and immunotherapy delivery.
  • To investigate the synergistic effect of SN38 and STING activation in modulating the TME.
  • To enhance antigen cross-presentation and convert immunosuppressive TME to immunogenic TME.

Main Methods:

  • Systemic and concurrent delivery of SN38 (chemotherapeutic) and DMXAA (STING agonist) using triblock copolymer nanoparticles (PS3D1@DMXAA).
  • Evaluation of the nanosystem's ability to enhance antigen cross-presentation and convert TME.
  • Assessment of therapeutic efficacy in three mouse tumor models, including combination with anti-PD-1 therapy.

Main Results:

  • PS3D1@DMXAA nanoparticles successfully delivered SN38 and DMXAA concurrently into tumors.
  • The combination demonstrated a synergistic function, converting immunosuppressive TME to immunogenic TME.
  • Significant therapeutic efficacy was observed in mouse tumor models, with enhanced benefit when combined with anti-PD-1 therapy.

Conclusions:

  • The engineered PS3D1@DMXAA nanosystem effectively converts "cold" tumors into "hot" tumors.
  • This strategy addresses major challenges in cancer immunotherapy by overcoming TME-related limitations.
  • The findings offer a rational design for effective immunotherapy combination regimens.